Microba Life Sciences Limited provides microbiome testing, supplements, and analysis services in Australia, Europe, New Zealand, the United Arab Emirates, the United Kingdom, the United States, Asia, and Ireland. It operates through, Testing Services and Supplements, and Research and Development segments. The company also develops pathology, therapeutics, and diagnostics services based on the human gut microbiome. In addition, it offers MetaPanel, a metagenomic test for pathogen detection; microba microbiome explorer; research testing services; and data-driven therapeutics platform that develops therapies for ulcerative colitis, inflammatory bowel autoimmune diseases, oncology, and allergy. Microba Life Sciences Limited was incorporated in 2017 and is based in Brisbane, Australia.
Price analytics
Returns
1 day
0.0%
1 week
-3.9%
1 month
-10.9%
3 months
28.9%
6 months
-29.0%
1 year
-42.4%
3 years
-83.8%
Risk
Volatility (1y ann.)
70.5%
Beta vs ASX 200
0.08
Sharpe (1y)
-0.48
VaR 95% (1-day)
-7.0%
Max drawdown (1y)
-64.0%
Off 1-year high
-51.0%
Technicals
RSI(14)
33
vs 50DMA
-5.4%
vs 200DMA
-25.5%
Trend
Death cross
Fundamental trends
Financial statements
Loading…
Scoring breakdown
(2 Oct 2026)
Value95.2
Trailing P/E
—
Forward P/E
100
PEG ratio
—
EV / EBITDA
100
Price / Book
92
Price / Sales
83
Growth100.0
Revenue growth (1y)
100
Revenue CAGR (3y)
100
EPS growth (1y)
—
EPS CAGR (3y)
—
Financial Health46.5
Net debt / EBITDA
—
Interest coverage (EBIT/interest)
0
Current ratio
26
Debt / Equity
100
Quality (Profitability & Cash Flow)0.0
Return on equity
0
Return on assets
0
Operating margin
0
Net margin
0
Cash conversion (OCF / net income)
—
Dividend / Income—
No meaningful dividend — pillar excluded from the overall score.
Momentum8.8
6-month return vs ASX 200
0
Price vs 200-day average
0
Price vs 50-day average
23
Position in 52-week range
19
Hover a row's info icon for the exact rule. Bounds and weights are configurable in
the Django admin (Scoring configuration).